#United States #Nashville #3 Boomerang #Enjoin #Kaitlyn Labuda

Enjoin Expands Executive Leadership Team

On March 4, 2025, Enjoin, a prominent player in healthcare revenue integrity, announced a notable addition to its executive leadership team. Kaitlyn Labuda has been appointed as the Executive Vice President of Product, a strategic move expected to bolster Enjoin's technology initiatives and accelerate product development as the company enters a new growth phase.

Enjoin, backed by the healthcare-focused private equity firm 3 Boomerang Capital, is recognized for its physician-directed services that enhance mid-revenue cycle operations. The company aims to leverage Kaitlyn's extensive experience to drive positive changes in its technology strategy, especially focusing on predictive analytics and artificial intelligence in healthcare.

Key Role and Responsibilities

In her new role, Kaitlyn Labuda is tasked with expanding Enjoin's AI presence by utilizing years of clinical and coding expertise surrounding every patient discharge. This initiative aims to improve documentation accuracy and overall revenue integrity within healthcare systems. Her approach, characterized by innovation and discipline, resonates with Enjoin’s dedication to achieving excellence in medical documentation.

Before joining Enjoin, Kaitlyn played an instrumental role in developing a cloud-based Clinical Documentation Integrity (CDI) solution, which garnered a prestigious ‘Best in KLAS’ award. Her academic background includes a bachelor’s degree in Health Information Management from the University of Pittsburgh, equipping her with the knowledge and skills necessary to excel in her new position.

Statements from Leadership

Justin Schmidt, the CEO of Enjoin, commented on this strategic hiring, stating, "This new role reflects our commitment to strengthening our leadership team and positioning the company for accelerated growth as it builds upon its strong foundation in mid-revenue cycle. As we continue to expand our capabilities and deliver exceptional value to our clients, Kaitlyn's expertise will be instrumental in driving our product strategies forward."

This appointment is part of Enjoin's broader strategy to enhance its technological framework, aiming to offer advanced solutions that improve the quality of clinical documentation and coding processes. With Kaitlyn at the helm of product development, Enjoin is poised to innovate further and extend its reach in the healthcare sector.

About Enjoin

Enjoin boasts over 35 years of experience in helping healthcare organizations accurately capture patient narratives while aligning physician-led services to improve mid-revenue cycle functions. With a team composed of experienced physicians and certified coding professionals, Enjoin has pioneered practices that not only enhance documentation and compliance but also dovetail with client goals to produce significant improvements in Clinical Modification Index (CMI), coding precision, and overall healthcare quality metrics. Clients have reported an impressive return on investment, averaging over 700% due to Enjoin's innovative strategies.

About 3 Boomerang Capital

3 Boomerang Capital, the private equity firm that backs Enjoin, focuses on lower middle-market healthcare investments across North America and Western Europe. Known for fostering creative partnerships with healthcare entrepreneurs, the firm specializes in supporting founder-led organizations. By concentrating on specific sectors like biopharma outsourcing, medical devices, IT services, and alternate site care, 3 Boomerang Capital empowers healthcare businesses to achieve sustainable growth and excellence in their operations.

Conclusion

The appointment of Kaitlyn Labuda as the Executive VP of Product marks a significant advancement in Enjoin's mission to offer cutting-edge technology solutions in the healthcare industry. As the firm continues its trajectory of growth, the insights and expertise that Kaitlyn brings to the team will prove essential in navigating the complexities of healthcare technology and ensuring that Enjoin remains at the forefront of innovation in revenue integrity.

For more information about Enjoin and its services, visit www.enjoincdi.com.